immuno-oncology Archives -

Roche steps up Merck challenge with first-line NSCLC approval in US

https://pharmaphorum.com/news/roche-continues-merck-challenge-with-first-line-nsclc-approval-in-us/

FDA sets January action date for Keytruda in early bladder cancer

https://pharmaphorum.com/news/fda-sets-january-action-date-for-keytruda-in-early-bladder-cancer/

BMS’ Opdivo/Yervoy combo hits a snag in adjuvant melanoma

https://pharmaphorum.com/news/bms-opdivo-yervoy-combo-hits-a-snag-in-adjuvant-melanoma/

FDA decision on Opdivo/Yervoy in liver cancer due next March

https://pharmaphorum.com/news/fda-decision-on-opdivo-yervoy-in-liver-cancer-due-next-march/

UK startup Ervaxx targets ‘dark matter’ of human genome

https://pharmaphorum.com/news/uk-startup-ervaxx-targets-dark-matter-of-human-genome/

Finally, AZ claims a win with Imfinzi/tremelimumab cancer combo

https://pharmaphorum.com/news/finally-az-claims-a-win-with-imfinzi-tremelimumab-cancer-combo/

4th Annual PREDiCT Tumor Models San Francisco

https://pharmaphorum.com/events/4th-annual-predict-tumor-models-san-francisco/

BMS gets a much-needed win with Opdivo in first-line lung cancer

https://pharmaphorum.com/news/bms-gets-a-much-needed-win-with-opdivo-in-first-line-lung-cancer/

Keytruda combo cleared as first-line kidney cancer treatment in EU

https://pharmaphorum.com/news/keytruda-combo-cleared-first-line-kidney-cancer-treatment-eu/

Search